FOXO1 links KRAS G12D and G12V alleles to glutamine and nitrogen metabolism in colorectal cancer
RNA-seq (gene expression) · human · 16 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Colorectal cancerThis series is part of our curated briefing on it.
- Samples
- 16 samples: 16 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- FOXO1 links KRAS G12D and G12V alleles to glutamine and nitrogen metabolism in colorectal cancerEMBO reports · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE306286_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1310415 and SRA study SRP612453. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 10 samples read as cases, 4 as controls.
How we read this: Read from 16 sample titles: 16 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9196816 Isogenic SW48 cell line (parental, wild-type for KRAS)
- GSM9196817 Isogenic SW48 mutant cell line (SW48 KRAS +/G12A)
- GSM9196818 Isogenic SW48 mutant cell line (SW48 KRAS +/G12C)
- GSM9196819 Isogenic SW48 mutant cell line (SW48 KRAS +/G12D)
- GSM9196820 Isogenic SW48 mutant cell line (SW48 KRAS +/G12V)
- GSM9196821 Isogenic SW48 cell line (parental, wild-type for KRAS) - low nutrient conditions
- GSM9196822 Isogenic SW48 mutant cell line (SW48 KRAS +/G12A) - low nutrient conditions
- GSM9196823 Isogenic SW48 mutant cell line (SW48 KRAS +/G12C) - low nutrient conditions
- GSM9196824 Isogenic SW48 mutant cell line (SW48 KRAS +/G12D) - low nutrient conditions
- GSM9196825 Isogenic SW48 mutant cell line (SW48 KRAS +/G12V - low nutrient conditions
- GSM9196826 Isogenic SW48 cell line (parental, wild-type for KRAS) - low nutrient conditions - DMSO control
- GSM9196827 Isogenic SW48 mutant cell line (SW48 KRAS +/G12C) - low nutrient conditions - DMSO control
- GSM9196828 Isogenic SW48 mutant cell line (SW48 KRAS +/G12D) - low nutrient conditions - DMSO control
- GSM9196829 Isogenic SW48 cell line (parental, wild-type for KRAS) - low nutrient conditions - FOXO1 inhibitor
- GSM9196830 Isogenic SW48 mutant cell line (SW48 KRAS +/G12C) - low nutrient conditions - FOXO1 inhibitor
- GSM9196831 Isogenic SW48 mutant cell line (SW48 KRAS +/G12D) - low nutrient conditions - FOXO1 inhibitor
- GSE250000 Bulk RNA-sequencing of transduced colorectal cancer cell line HCT-116 and breast cancer cell line MCF-7 overexpressing full-lenght p53β or p53β-stop-lost. 4 samples same disease briefing · shares colorectal
- GSE12032 Inherent gene signature of stage II and III colorectal cancer leads in individual recurrence 198 samples same disease briefing · shares colorectal
- GSE109308 Single-cell transcriptomic survey of adenomatous polyposis patients with germline APC mutations 97 samples same disease briefing
- GSE110009 Single cell transcriptome landscape of primary and metastatic tumor in colon cancer 76 samples same disease briefing
- GSE279749 Combination of PARP and KRAS G12D Inhibitors Enhances Efficacy of Therapeutic Vulnerabilities 30 samples shares kras, g12d
- GSE309499 HDAC5 Deficiency Induces Intrinsic Resistance to KRASG12D Inhibition by Disrupting c-Myc Acetylation-Ubiquitination Homeostasis [RNA-seq] 12 samples shares kras, g12d
- GSE290526 VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation [scRNA-Seq] 3 samples shares kras, g12d
- GSE309501 HDAC5 Deficiency Induces Intrinsic Resistance to KRASG12D Inhibition by Disrupting c-Myc Acetylation-Ubiquitination Homeostasis [ChIP-Seq] 6 samples shares kras, g12d
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.